RARECast
Podcast készítő RARECast - Csütörtökök
548 Epizód
-
How One Drugmaker Reaches out to Communities at Greater Risk for Rare Heart Condition
Közzétéve: 2023. 03. 03. -
A Next-Generation RNA Therapy Targets Telomere Disorders
Közzétéve: 2023. 03. 03. -
BridgeBio Advances Therapy for Limb-Girdle Muscular Dystrophy that Started with Two Patient Families
Közzétéve: 2023. 02. 24. -
Translating Urgency into Science
Közzétéve: 2023. 02. 16. -
Empowering Ultra-Rare Disease Patients to Pursue the Discovery of Treatments
Közzétéve: 2023. 02. 10. -
Why a Topical Cannabidiol Gel May Help Treat the Behavioral Symptoms of Fragile X
Közzétéve: 2023. 02. 02. -
An Ultra-Rare Disease Drug Developer Tries to Navigate Regulatory Uncertainty
Közzétéve: 2023. 01. 26. -
Powering Cells in People with Rare Mitochondrial Diseases
Közzétéve: 2023. 01. 19. -
Powering Weakened and Stressed Cells in ALS to Function Better with Nanocrystal Therapy
Közzétéve: 2023. 01. 12. -
Developing a New Class of Therapies Based on a Natural Cargo Carrier
Közzétéve: 2023. 01. 05. -
Reaching Beyond the Limits of Enzyme Replacement Therapies with Gene Therapies
Közzétéve: 2022. 12. 29. -
One Woman’s Journey as a Caregiver to a Husband with Frontotemporal Dementia
Közzétéve: 2022. 12. 22. -
Treating Rare Endocrine Disorders with Therapeutic Peptides
Közzétéve: 2022. 12. 15. -
Tackling the Pricing Challenges for Advanced Therapies for Rare Diseases
Közzétéve: 2022. 12. 08. -
Addressing the Current Limitations of AAV Gene Therapies
Közzétéve: 2022. 12. 01. -
Examining the Legislative Landscape for Rare Disease Drug Development
Közzétéve: 2022. 11. 24. -
How a Drug Setback Became a Patient Community’s Gain
Közzétéve: 2022. 11. 18. -
Helping Regulators and Drug Developers Understand the Challenges of Living with Fabry Disease
Közzétéve: 2022. 11. 10. -
Addressing Racial Disparities in a Rare Blood Cancer
Közzétéve: 2022. 11. 03. -
How New Sequencing Technology Promises to Alter the Diagnostic Odyssey
Közzétéve: 2022. 10. 27.
RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.
